Health House International Ltd
ASX:HHI

Watchlist Manager
Health House International Ltd Logo
Health House International Ltd
ASX:HHI
Watchlist
Price: 0.005 AUD Market Closed
Market Cap: AU$891.1k

Health House International Ltd
Investor Relations

Health House International Ltd. is an international distributor of medicinal cannabis. The company is headquartered in Perth, Western Australia. The company went IPO on 2011-07-28. Its primary activities include operations in the pharmaceutical wholesale and distribution sectors. The company has two operating subsidiaries: Health House Pharma Limited, an international pharmaceutical distribution business in the United Kingdom and Health House International Pty Limited, a medicinal cannabis distribution business in Australia. Th products distributed by the Company include iX Biopharma’s Xativa, which is formulated using WaferiX, which is patented sublingual delivery technology, and Zelira Therapeutics’ cannabinoid-based customized medicines, including HOPE1, HOPE2 and Zenivol oil blended with pharmaceutical-grade sunflower oil. The company distributes Levin Health’s cannabinoid-based, chronic pain medicines, such as LEVIN CBD 100 and LEVIN Balance 10:12. The company also distributes products of various companies, such as Satipharm, HAPA pharm, Ananda Hemp and Little Green Pharma.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
WESTERN AUSTRALIA
Perth
Level 3, 101 St Georges Terrace
Contacts
+61865580886.0
healthhouse.com.au
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett